11 research outputs found
Antiviral and cytotoxic activity of different plant parts of banana (Musa spp.)
Open Access Journal; Published online: 15 May 2020Chikungunya and yellow fever virus cause vector-borne viral diseases in humans. There is currently no specific antiviral drug for either of these diseases. Banana plants are used in traditional medicine for treating viral diseases such as measles and chickenpox. Therefore, we tested selected banana cultivars for their antiviral but also cytotoxic properties. Different parts such as leaf, pseudostem and corm, collected separately and extracted with four different solvents (hexane, acetone, ethanol, and water), were tested for in vitro antiviral activity against Chikungunya virus (CHIKV), enterovirus 71 (EV71), and yellow fever virus (YFV). Extracts prepared with acetone and ethanol from leaf parts of several cultivars exhibited strong (EC50 around 10 μg/mL) anti-CHIKV activity. Interestingly, none of the banana plant extracts (concentration 1–100 µg/mL) were active against EV71. Activity against YFV was restricted to two cultivars: Namwa Khom–Pseudostem–Ethanol (5.9 ± 5.4), Namwa Khom–Corm–Ethanol (0.79 ± 0.1) and Fougamou–Corm–Acetone (2.5 ± 1.5). In most cases, the cytotoxic activity of the extracts was generally 5- to 10-fold lower than the antiviral activity, suggesting a reasonable therapeutic window
Antimicrobial activity of selected banana cultivars against important human pathogens, including candida biofilm
Open Access JournalTen banana (Musa spp.) cultivars were studied for their antimicrobial properties. Three plant parts (corm, pseudostem and leaves) were collected separately and extracted with different solvents, viz., hexane, acetone, ethanol and water. The 50% inhibitory concentration (IC50) was evaluated using a broth microdilution assay. Eight human bacterial and one fungal pathogen were tested. Acetone and ethanol extract(s) often exhibited significant antimicrobial activity, while hexane extracts were less active. Aqueous extracts often showed microbial growth, possibly by endophytes. Leaf extracts were most active, followed by pseudostem, and corm was least active. All the tested banana cultivars were found to contain antimicrobials, as demonstrated by inhibition of selected human pathogens. However, cultivars such as Dole, Saba, Fougamou, Namwah Khom, Pelipita and Mbwazirume showed a broad-spectrum activity, inhibiting all tested pathogens. Other cultivars such as Petit Naine and Kluai Tiparot showed a narrow-spectrum activity, including antibiofilm activity against Candida albicans. Our results support the use of different parts of banana plants in traditional human medicine for infections, including diarrhea and dysentery, and some sexually transmitted diseases, as well as for packaging spoilable materials like food
Identificação de espécies da família Asteraceae, revisão sobre usos e triagem fitoquímica do gênero Eremanthus da Reserva Boqueirão, Ingaí-MG
Com o objetivo de identificar espécies da família Asteraceae, revisar seus usos e realizar triagem fitoquímica preliminar do gênero Eremanthus procederam-se coletas botânicas semanais de espécimes na Reserva Boqueirão, localizada em Ingaí, Minas Gerais. As amostras foram herborizadas e identificadas utilizando-se bibliografia especializada e comparação com espécimes disponíveis no Herbário ESAL, da Universidade Federal de Lavras. A revisão dos usos foi feita através de consulta a obras clássicas e artigos científicos contendo relatos sobre levantamentos etnobotânicos realizados na área de estudo. Para triagem fitoquímica empregaram-se reagentes específicos para cada grupo de metabólito. Foram levantadas 102 espécies da família Asteraceae, sendo 32 delas úteis para o homem. A triagem fitoquímica dos extratos hidroalcoólicos indicaram a presença de açúcares redutores, carboidratos, aminoácidos, taninos, flavonóides, glicosídeos cardiotônicos, carotenóides, esteróides e triterpenóides, depsídeos e depsidonas, derivados de cumarina, saponinas espumídicas, alcalóides, purinas, polissacarídeos e antraquinonas. Não foram detectados ácidos orgânicos, catequinas, lactonas sesquiterpênicas e azulenos
Assessment of antimicrobial activity in vitro of ethanolic extracts of Banisteriopsis anisandra (A. Juss.) B. Gates (Malpighiaceae)
The aim of this study was to evaluate the antimicrobial activity in vitro of ethanolic extracts of Banisteriopsis anisandra. Tests were performed using the extracts overlay method in the culture medium for phytopathogenic fungi Rhizoctonia solani and Fusarium oxysporum, and disk diffusion for the microorganisms Staphylococcus aureus and Candida albicans. Ethanolic extracts from leaves were prepared by maceration (extract I) and decoction (extract II) at 430.0, 215.0 and 107.5 mg/mL. The growth inhibition of R. solani and F. oxysporum was determined by calculating the mycelia growth speed rate (MGSR) and, in relation C. albicans and S. aureus, it was determined by measuring the inhibition halos. Extracts that caused significant inhibition were also tested at 86.0, 64.5, 43.0 and 21.5 mg/mL for C. albicans and S. aureus. Both extracts showed inhibitory activity on the microorganisms studied. Rizoctonia solani showed lower MGSR in the presence of extract II (107.5 mg/mL) and Fusarium oxysporum showed slight MGSR reduction in the presence of extract I (107.5 mg/mL) and II (107.5 and 215 mg/mL). Ethanolic extracts I and II inhibited the growth of C. albicans, with the highest rates of inhibition observed in the presence of extract II (215.0 mg/mL). For S. aureus, the highest inhibitory activity was observed in the presence of ethanolic extract II, prepared by decoction at 430.0 mg/mL. Results showed a promising antimicrobial activity of extracts of B. anisandra, which may contribute to further studies leading to a future development of medicines to treat human and plant diseases caused by these organisms
Produção de frutos para uso medicinal em Bromelia antiancatha (caraguatá): fundamentos para um extrastivismo sustentável Fruit production for medicinal use in Bromelia antiacantha ("caraguatá"): foundations for sustainable extraction
Entre as várias espécies que têm sido utilizadas como fontes de subprodutos florestais estão a Bromelia antiacantha, espécie nativa da Mata Atlântica com grande potencial de uso com características alimentícias, ornamentais, industriais e farmacológicas. Os frutos da espécie são utilizados tradicionalmente no Planalto Norte Catarinense na confecção de xaropes para tratamento de males das vias respiratórias. Neste contexto, objetivou-se quantificar a produção de frutos e fundamentar estratégias para possível manejo de populações naturais de B. antiacantha. Foram acompanhadas 39 infrutescências de Janeiro/2008 a Agosto/2008 distribuídas em área de mata secundária na FLONA de Três Barras, SC. Nesta mesma área, indivíduos da espécie foram acompanhados através de estudos demográficos de 2001 a 2008. As infrutescências apresentaram em média 0,68m de comprimento, número médio de 187 frutos/infrutescência, o diâmetro médio dos frutos foi de 1,9 cm e o peso médio das infrutescências de 3,6 kg. A média de frutos aproveitáveis foi de 157 frutos/infrutescência totalizando 2,5 kg. A safra estimada para 2005 foi de 146 kg de frutos ha-1 e 80 kg de frutos ha-1 para 2008, e a renda líquida a partir da produção de xarope foi estimada em R 1168.00 per hectare per year. The results showed that the management of B. antiacantha consists in an economically interesting activity and that this possibility complements the income of local communities where the species occurs, besides increasing the value of forest areas